# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-25-214176
Filing Date
2025-09-24
Accepted
2025-09-24 08:30:22
Documents
62
Period of Report
2025-09-24
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d76224d8k.htm iXBRL | 8-K | 25059
2 | EX-99.1 | d76224dex991.htm | EX-99.1 | 51317
6 | GRAPHIC | g76224ex99_1p10g1.jpg | GRAPHIC | 206166
7 | GRAPHIC | g76224ex99_1p11g1.jpg | GRAPHIC | 229108
8 | GRAPHIC | g76224ex99_1p12g1.jpg | GRAPHIC | 266390
9 | GRAPHIC | g76224ex99_1p13g1.jpg | GRAPHIC | 264279
10 | GRAPHIC | g76224ex99_1p14g1.jpg | GRAPHIC | 279237
11 | GRAPHIC | g76224ex99_1p15g1.jpg | GRAPHIC | 272812
12 | GRAPHIC | g76224ex99_1p16g1.jpg | GRAPHIC | 218604
13 | GRAPHIC | g76224ex99_1p17g1.jpg | GRAPHIC | 166705
14 | GRAPHIC | g76224ex99_1p18g1.jpg | GRAPHIC | 296942
15 | GRAPHIC | g76224ex99_1p19g1.jpg | GRAPHIC | 257924
16 | GRAPHIC | g76224ex99_1p1g1.jpg | GRAPHIC | 299579
17 | GRAPHIC | g76224ex99_1p20g1.jpg | GRAPHIC | 225180
18 | GRAPHIC | g76224ex99_1p21g1.jpg | GRAPHIC | 189471
19 | GRAPHIC | g76224ex99_1p22g1.jpg | GRAPHIC | 279603
20 | GRAPHIC | g76224ex99_1p23g1.jpg | GRAPHIC | 256613
21 | GRAPHIC | g76224ex99_1p24g1.jpg | GRAPHIC | 291729
22 | GRAPHIC | g76224ex99_1p25g1.jpg | GRAPHIC | 219160
23 | GRAPHIC | g76224ex99_1p26g1.jpg | GRAPHIC | 206935
24 | GRAPHIC | g76224ex99_1p27g1.jpg | GRAPHIC | 146867
25 | GRAPHIC | g76224ex99_1p28g1.jpg | GRAPHIC | 291927
26 | GRAPHIC | g76224ex99_1p29g1.jpg | GRAPHIC | 291139
27 | GRAPHIC | g76224ex99_1p2g1.jpg | GRAPHIC | 371440
28 | GRAPHIC | g76224ex99_1p30g1.jpg | GRAPHIC | 210292
29 | GRAPHIC | g76224ex99_1p31g1.jpg | GRAPHIC | 198067
30 | GRAPHIC | g76224ex99_1p32g1.jpg | GRAPHIC | 318885
31 | GRAPHIC | g76224ex99_1p33g1.jpg | GRAPHIC | 178342
32 | GRAPHIC | g76224ex99_1p34g1.jpg | GRAPHIC | 277355
33 | GRAPHIC | g76224ex99_1p35g1.jpg | GRAPHIC | 253634
34 | GRAPHIC | g76224ex99_1p36g1.jpg | GRAPHIC | 286066
35 | GRAPHIC | g76224ex99_1p37g1.jpg | GRAPHIC | 190821
36 | GRAPHIC | g76224ex99_1p38g1.jpg | GRAPHIC | 251357
37 | GRAPHIC | g76224ex99_1p39g1.jpg | GRAPHIC | 241145
38 | GRAPHIC | g76224ex99_1p3g1.jpg | GRAPHIC | 256720
39 | GRAPHIC | g76224ex99_1p40g1.jpg | GRAPHIC | 146500
40 | GRAPHIC | g76224ex99_1p41g1.jpg | GRAPHIC | 325989
41 | GRAPHIC | g76224ex99_1p42g1.jpg | GRAPHIC | 293432
42 | GRAPHIC | g76224ex99_1p43g1.jpg | GRAPHIC | 249353
43 | GRAPHIC | g76224ex99_1p44g1.jpg | GRAPHIC | 207204
44 | GRAPHIC | g76224ex99_1p45g1.jpg | GRAPHIC | 241156
45 | GRAPHIC | g76224ex99_1p46g1.jpg | GRAPHIC | 150325
46 | GRAPHIC | g76224ex99_1p47g1.jpg | GRAPHIC | 252409
47 | GRAPHIC | g76224ex99_1p48g1.jpg | GRAPHIC | 223895
48 | GRAPHIC | g76224ex99_1p49g1.jpg | GRAPHIC | 179638
49 | GRAPHIC | g76224ex99_1p4g1.jpg | GRAPHIC | 305471
50 | GRAPHIC | g76224ex99_1p5g1.jpg | GRAPHIC | 230235
51 | GRAPHIC | g76224ex99_1p6g1.jpg | GRAPHIC | 218926
52 | GRAPHIC | g76224ex99_1p7g1.jpg | GRAPHIC | 140393
53 | GRAPHIC | g76224ex99_1p8g1.jpg | GRAPHIC | 251543
54 | GRAPHIC | g76224ex99_1p9g1.jpg | GRAPHIC | 273539
| Complete submission text file | 0001193125-25-214176.txt |  | 16578906

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | wve-20250924.xsd | EX-101.SCH | 2872
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | wve-20250924_lab.xml | EX-101.LAB | 17924
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | wve-20250924_pre.xml | EX-101.PRE | 11252
64 | EXTRACTED XBRL INSTANCE DOCUMENT | d76224d8k_htm.xml | XML | 3613

Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 251335347
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)